Cargando…

An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation

BACKGROUND: Hepatitis B virus (HBV) infection is one of the main causes of hepatocellular carcinoma (HCC). The relationship between HBV infection and the host genome as well as their underlying mechanisms remain largely unknown. METHODS: In this study, we performed a whole-genome exon sequencing ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bin, Han, Haijun, Zhao, Xinyi, Li, Andria N., Wang, Yan, Yuan, Wenji, Yang, Zhongli, Li, Ming D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435766/
https://www.ncbi.nlm.nih.gov/pubmed/37442062
http://dx.doi.org/10.1016/j.ebiom.2023.104694
_version_ 1785092177184948224
author Zhang, Bin
Han, Haijun
Zhao, Xinyi
Li, Andria N.
Wang, Yan
Yuan, Wenji
Yang, Zhongli
Li, Ming D.
author_facet Zhang, Bin
Han, Haijun
Zhao, Xinyi
Li, Andria N.
Wang, Yan
Yuan, Wenji
Yang, Zhongli
Li, Ming D.
author_sort Zhang, Bin
collection PubMed
description BACKGROUND: Hepatitis B virus (HBV) infection is one of the main causes of hepatocellular carcinoma (HCC). The relationship between HBV infection and the host genome as well as their underlying mechanisms remain largely unknown. METHODS: In this study, we performed a whole-genome exon sequencing analysis of 300 sib-pairs of Chinese HBV-infected families with the goal of identifying variants and genes involved in HBV infection. A site-direct mutant plasmid was used to investigate the function of SNP rs76438938 in KNG1. The functional and mechanical studies of KNG1 were conducted with in vitro liver cell lines and a hydrodynamic injection model in vivo. The impact of KNG1 on HBV infection therapy was determined in hepatocytes treated with IFN-α/λ1. FINDINGS: Our whole-exon association study of 300 families with hepatitis B infection found that SNP rs76438938 in KNG1 significantly increased the risk for HBV infection, and the rs76438938-T allele was found to promote HBV replication by increasing the stability of KNG1 mRNA. By competitively binding HSP90A with MAVS, KNG1 can inhibit the expression of types I and III IFNs by promoting MAVS lysosomal degradation. Such suppression of IFN expression and promotion of HBV replication by Kng1 were further demonstrated with an animal model in vivo. Lastly, we showed that the rs76438938-C allele can improve the therapeutic effect of IFN-α and -λ1 in HBV infection. INTERPRETATION: This study identified a SNP, rs76438938, in a newly discovered host gene, KNG1, for its involvement in HBV infection and treatment effect through modulating the cellular antiviral process. FUNDING: This study was supported in part by the Independent Task of 10.13039/501100011441State Key Laboratory for Diagnosis and Treatment of Infectious Diseases of the First Affiliated Hospital of 10.13039/501100004835Zhejiang University, the China Precision Medicine Initiative (2016YFC0906300), and the Research Center for Air Pollution and Health of 10.13039/501100004835Zhejiang University.
format Online
Article
Text
id pubmed-10435766
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-104357662023-08-19 An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation Zhang, Bin Han, Haijun Zhao, Xinyi Li, Andria N. Wang, Yan Yuan, Wenji Yang, Zhongli Li, Ming D. eBioMedicine Articles BACKGROUND: Hepatitis B virus (HBV) infection is one of the main causes of hepatocellular carcinoma (HCC). The relationship between HBV infection and the host genome as well as their underlying mechanisms remain largely unknown. METHODS: In this study, we performed a whole-genome exon sequencing analysis of 300 sib-pairs of Chinese HBV-infected families with the goal of identifying variants and genes involved in HBV infection. A site-direct mutant plasmid was used to investigate the function of SNP rs76438938 in KNG1. The functional and mechanical studies of KNG1 were conducted with in vitro liver cell lines and a hydrodynamic injection model in vivo. The impact of KNG1 on HBV infection therapy was determined in hepatocytes treated with IFN-α/λ1. FINDINGS: Our whole-exon association study of 300 families with hepatitis B infection found that SNP rs76438938 in KNG1 significantly increased the risk for HBV infection, and the rs76438938-T allele was found to promote HBV replication by increasing the stability of KNG1 mRNA. By competitively binding HSP90A with MAVS, KNG1 can inhibit the expression of types I and III IFNs by promoting MAVS lysosomal degradation. Such suppression of IFN expression and promotion of HBV replication by Kng1 were further demonstrated with an animal model in vivo. Lastly, we showed that the rs76438938-C allele can improve the therapeutic effect of IFN-α and -λ1 in HBV infection. INTERPRETATION: This study identified a SNP, rs76438938, in a newly discovered host gene, KNG1, for its involvement in HBV infection and treatment effect through modulating the cellular antiviral process. FUNDING: This study was supported in part by the Independent Task of 10.13039/501100011441State Key Laboratory for Diagnosis and Treatment of Infectious Diseases of the First Affiliated Hospital of 10.13039/501100004835Zhejiang University, the China Precision Medicine Initiative (2016YFC0906300), and the Research Center for Air Pollution and Health of 10.13039/501100004835Zhejiang University. Elsevier 2023-07-11 /pmc/articles/PMC10435766/ /pubmed/37442062 http://dx.doi.org/10.1016/j.ebiom.2023.104694 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Articles
Zhang, Bin
Han, Haijun
Zhao, Xinyi
Li, Andria N.
Wang, Yan
Yuan, Wenji
Yang, Zhongli
Li, Ming D.
An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
title An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
title_full An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
title_fullStr An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
title_full_unstemmed An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
title_short An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation
title_sort hbv susceptibility variant of kng1 modulates the therapeutic effects of interferons α and λ1 in hbv infection by promoting mavs lysosomal degradation
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435766/
https://www.ncbi.nlm.nih.gov/pubmed/37442062
http://dx.doi.org/10.1016/j.ebiom.2023.104694
work_keys_str_mv AT zhangbin anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT hanhaijun anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT zhaoxinyi anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT liandrian anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT wangyan anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT yuanwenji anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT yangzhongli anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT limingd anhbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT zhangbin hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT hanhaijun hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT zhaoxinyi hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT liandrian hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT wangyan hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT yuanwenji hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT yangzhongli hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation
AT limingd hbvsusceptibilityvariantofkng1modulatesthetherapeuticeffectsofinterferonsaandl1inhbvinfectionbypromotingmavslysosomaldegradation